• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于酸不稳定释放杂交胶束以促进协同抗肿瘤功效的细菌微机器人。

Bacterial microbots for acid-labile release of hybrid micelles to promote the synergistic antitumor efficacy.

机构信息

Key Laboratory of Advanced Technologies of Materials, Ministry of Education, School of Materials Science and Engineering, Southwest Jiaotong University, Chengdu 610031, PR China.

Key Laboratory of Advanced Technologies of Materials, Ministry of Education, School of Materials Science and Engineering, Southwest Jiaotong University, Chengdu 610031, PR China.

出版信息

Acta Biomater. 2018 Sep 15;78:198-210. doi: 10.1016/j.actbio.2018.07.041. Epub 2018 Jul 21.

DOI:10.1016/j.actbio.2018.07.041
PMID:30036720
Abstract

UNLABELLED

Bacteria have inherent properties of self-propelled navigation and specific infiltration into solid tumors. In the current study, we investigate a novel type of bacterial microbots for delivery of hybrid micelles to promote the synergistic antitumor efficacy. Escherichia coli Nissle 1917 (EcN) is used as a bacterial carrier to immobilize amphiphilic copolymers through acid-labile 2-propionic-3-methylmaleic anhydride (CDM) linkers. Doxorubicin (DOX) and α-tocopheryl succinate (TOS) are conjugated with poly(ethylene glycol) through disulfide linkers to obtain amphiphilic promicelle polymers (PM and PM). Tetrazine and norbornene terminals are grafted on EcN and PM/PM copolymers, respectively, and the mild and site-specific bioorthogonal reaction between them maintains the viability, motion ability, and tumor accumulation capability of the conjugated EcN. The PM/PM copolymers are released from bacterial microbots in response to the slightly acidic tumor microenvironment, followed by in situ formation of these copolymers as hybrid micelles (M). The self-assembled micelles from PM/PM with a ratio of 1:2 demonstrate the most significant synergistic efficacy, and the released M hybrid micelles exhibit cellular uptake efficiency, glutathione (GSH)-sensitive drug release, and cytotoxicities similar to those exhibited by micelles prepared by solvent evaporation. Because of the consecutive process of the self-propelling nature of bacteria and preferential accumulation of EcN in tumors, in situ formation of M hybrid micelles, and intracellular drug release, bacterial microbots have shown remarkable antitumor efficacy with regard to animal survival, tumor growth, and apoptosis induction in tumor cells. Therefore, we demonstrate a feasible strategy for the construction of bacterial microbots to achieve tumor accumulation and on-demand release of multiple therapeutic agents for synergistic antitumor efficacy.

STATEMENT OF SIGNIFICANCE

Challenges remain in the targeted delivery of nanoparticles to solid tumors and the realization of synergistic efficacy in cancer chemotherapy. In the current study, we explore a novel class of bacterial microbots to load, deliver, and release hybrid micelles. Escherichia coli Nissle 1917 (EcN) is used as a bacterial carrier to immobilize amphiphilic copolymers through acid-labile linkers, and the released copolymers are self-assembled into micelles. The resulting bacterial microbots integrate self-propelling bacteria and self-assembling amphiphilic polymers into micelles and realize pH-responsive release of promicelle polymers from bacterial microbots and glutathione-responsive intracellular release of drugs. A synergistic antitumor efficacy is achieved using hybrid micelles, which release both doxorubicin and α-tocopheryl succinate to display toxicities in the nucleus and mitochondria, respectively.

摘要

未加标签

细菌具有自主导航和特异性渗透入实体瘤的固有特性。在本研究中,我们研究了一种新型细菌微机器人用于传递混合胶束以促进协同抗肿瘤疗效。大肠杆菌 Nissle 1917(EcN)被用作细菌载体,通过酸不稳定的 2-丙稀酸-3-甲基马来酸酐(CDM)连接物固定两亲共聚物。阿霉素(DOX)和 α-生育酚琥珀酸酯(TOS)通过二硫键连接到聚乙二醇上,得到两亲性前胶束聚合物(PM 和 PM)。四嗪和降冰片烯末端分别接枝在 EcN 和 PM/PM 共聚物上,温和的、位点特异性的生物正交反应保持了共轭 EcN 的活力、运动能力和肿瘤积累能力。PM/PM 共聚物在响应轻微酸性肿瘤微环境时从细菌微机器人中释放出来,然后原位形成这些共聚物作为混合胶束(M)。PM/PM 以 1:2 的比例自组装成的胶束表现出最显著的协同疗效,释放的 M 混合胶束表现出类似通过溶剂蒸发制备的胶束的细胞摄取效率、谷胱甘肽(GSH)敏感药物释放和细胞毒性。由于细菌的自主推进特性和 EcN 优先积累在肿瘤中的连续过程,原位形成 M 混合胶束和细胞内药物释放,细菌微机器人在动物生存、肿瘤生长和肿瘤细胞凋亡诱导方面表现出显著的抗肿瘤疗效。因此,我们展示了一种构建细菌微机器人的可行策略,用于实现肿瘤积累和按需释放多种治疗剂以实现协同抗肿瘤疗效。

意义声明

在将纳米颗粒靶向递送至实体瘤和实现癌症化疗中的协同疗效方面仍然存在挑战。在本研究中,我们探索了一类新型细菌微机器人来负载、递送和释放混合胶束。大肠杆菌 Nissle 1917(EcN)被用作细菌载体,通过酸不稳定的连接物固定两亲共聚物,释放的共聚物自组装成胶束。所得细菌微机器人将自主推进的细菌和自组装的两亲性聚合物整合到胶束中,并实现了从细菌微机器人中响应 pH 释放前胶束聚合物和响应谷胱甘肽释放药物的细胞内释放。通过混合胶束实现了协同抗肿瘤疗效,混合胶束释放阿霉素和 α-生育酚琥珀酸酯分别在核和线粒体中显示毒性。

相似文献

1
Bacterial microbots for acid-labile release of hybrid micelles to promote the synergistic antitumor efficacy.用于酸不稳定释放杂交胶束以促进协同抗肿瘤功效的细菌微机器人。
Acta Biomater. 2018 Sep 15;78:198-210. doi: 10.1016/j.actbio.2018.07.041. Epub 2018 Jul 21.
2
Synergistic antitumor efficacy of redox and pH dually responsive micelleplexes for co-delivery of camptothecin and genes.用于共递送喜树碱和基因的氧化还原与pH双重响应性胶束复合物的协同抗肿瘤疗效
Acta Biomater. 2017 Feb;49:444-455. doi: 10.1016/j.actbio.2016.12.005. Epub 2016 Dec 7.
3
Synergistic antitumor efficacy of hybrid micelles with mitochondrial targeting and stimuli-responsive drug release behavior.具有线粒体靶向和刺激响应药物释放行为的杂化胶束的协同抗肿瘤功效。
J Mater Chem B. 2019 Mar 7;7(9):1415-1426. doi: 10.1039/c8tb02843e. Epub 2019 Feb 4.
4
Tumor pH-Responsive Release of Drug-Conjugated Micelles from Fiber Fragments for Intratumoral Chemotherapy.纤维碎片药物偶联胶束的肿瘤 pH 响应性释放用于肿瘤内化疗。
ACS Appl Mater Interfaces. 2017 Sep 27;9(38):32534-32544. doi: 10.1021/acsami.7b09519. Epub 2017 Sep 13.
5
Doxorubicin-conjugated Escherichia coli Nissle 1917 swimmers to achieve tumor targeting and responsive drug release.阿霉素偶联大肠杆菌 Nissle 1917 泳动体以实现肿瘤靶向和响应性药物释放。
J Control Release. 2017 Dec 28;268:390-399. doi: 10.1016/j.jconrel.2017.10.041. Epub 2017 Oct 31.
6
An implantable depot capable of in situ generation of micelles to achieve controlled and targeted tumor chemotherapy.一种可植入的储库,能够原位生成胶束,实现肿瘤化疗的控制和靶向。
Acta Biomater. 2018 Feb;67:122-133. doi: 10.1016/j.actbio.2017.12.003. Epub 2017 Dec 12.
7
Acid-Labile Degradation of Injectable Fiber Fragments to Release Bioreducible Micelles for Targeted Cancer Therapy.可酸降解的注射纤维片段释放生物还原胶束用于靶向癌症治疗。
Biomacromolecules. 2018 Apr 9;19(4):1100-1110. doi: 10.1021/acs.biomac.7b01696. Epub 2018 Mar 15.
8
Escherichia coli Nissle 1917-driven microrobots for effective tumor targeted drug delivery and tumor regression.大肠杆菌 Nissle 1917 驱动的微机器人用于有效的肿瘤靶向药物递送和肿瘤消退。
Acta Biomater. 2023 Oct 1;169:477-488. doi: 10.1016/j.actbio.2023.07.051. Epub 2023 Aug 1.
9
A polymeric micelle with an endosomal pH-sensitivity for intracellular delivery and enhanced antitumor efficacy of hydroxycamptothecin.具有内涵体 pH 敏感性的聚合物胶束用于细胞内递药和增强喜树碱的抗肿瘤疗效。
Acta Biomater. 2019 Apr 1;88:357-369. doi: 10.1016/j.actbio.2019.02.039. Epub 2019 Feb 26.
10
PEG-Detachable Polymeric Micelles Self-Assembled from Amphiphilic Copolymers for Tumor-Acidity-Triggered Drug Delivery and Controlled Release.聚乙二醇修饰的两亲性嵌段共聚物聚合物胶束用于肿瘤酸性触发的药物递送和控制释放
ACS Appl Mater Interfaces. 2019 Feb 13;11(6):5701-5713. doi: 10.1021/acsami.8b13059. Epub 2019 Jan 29.

引用本文的文献

1
Resynthesis of synthetic biology techniques: combining engineered bacteria with other antitumour therapies.合成生物学技术的再合成:将工程菌与其他抗肿瘤疗法相结合。
Front Microbiol. 2025 Jul 28;16:1545334. doi: 10.3389/fmicb.2025.1545334. eCollection 2025.
2
Bacterial carrier-mediated drug delivery systems: a promising strategy in cancer therapy.细菌载体介导的药物递送系统:癌症治疗中的一种有前景的策略。
Front Bioeng Biotechnol. 2025 Jan 8;12:1526612. doi: 10.3389/fbioe.2024.1526612. eCollection 2024.
3
Enhancing the Anticancer Activity of Attenuated by Cell Wall Functionalization with "Clickable" Doxorubicin.
通过“点击化学”阿霉素对细胞壁功能化修饰增强减毒 的抗癌活性。
ACS Chem Biol. 2024 Oct 18;19(10):2131-2140. doi: 10.1021/acschembio.4c00250. Epub 2024 Sep 24.
4
Towards Understanding Tumour Colonisation by Probiotic Bacterium Nissle 1917.深入了解益生菌Nissle 1917对肿瘤的定殖作用
Cancers (Basel). 2024 Aug 26;16(17):2971. doi: 10.3390/cancers16172971.
5
The application of bacteria-nanomaterial hybrids in antitumor therapy.细菌-纳米材料杂合体在抗肿瘤治疗中的应用。
J Nanobiotechnology. 2024 Sep 4;22(1):536. doi: 10.1186/s12951-024-02793-x.
6
Bacterial derivatives mediated drug delivery in cancer therapy: a new generation strategy.细菌衍生物介导的药物传递在癌症治疗中的应用:新一代策略。
J Nanobiotechnology. 2024 Aug 24;22(1):510. doi: 10.1186/s12951-024-02786-w.
7
Meta-Analysis of Nanoparticle Distribution in Tumors and Major Organs in Tumor-Bearing Mice.肿瘤荷瘤小鼠中肿瘤和主要器官内纳米颗粒分布的荟萃分析。
ACS Nano. 2023 Oct 24;17(20):19810-19831. doi: 10.1021/acsnano.3c04037. Epub 2023 Oct 9.
8
Establishment of ultrasound-responsive SonoBacteriaBot for targeted drug delivery and controlled release.用于靶向给药和控释的超声响应性超声细菌机器人的构建。
Front Bioeng Biotechnol. 2023 Feb 24;11:1144963. doi: 10.3389/fbioe.2023.1144963. eCollection 2023.
9
Bacteria-Assisted Transport of Nanomaterials to Improve Drug Delivery in Cancer Therapy.细菌辅助纳米材料运输以改善癌症治疗中的药物递送
Nanomaterials (Basel). 2022 Jan 17;12(2):288. doi: 10.3390/nano12020288.
10
Native and Engineered Probiotics: Promising Agents against Related Systemic and Intestinal Diseases.本土益生菌和工程益生菌:对抗相关系统性和肠道疾病的有前途的制剂。
Int J Mol Sci. 2022 Jan 6;23(2):594. doi: 10.3390/ijms23020594.